Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus

scientific article published on 01 March 2002

Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ/EYE/6700095
P698PubMed publication ID11988817

P2093author name stringC Evereklioglu
H Er
S Doganay
Y Türköz
A Sevinç
H Savli
N Mehmet
P433issue2
P304page(s)163-170
P577publication date2002-03-01
P1433published inEyeQ10278937
P1476titleComparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus
P478volume16

Reverse relations

cites work (P2860)
Q52633243(Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy.
Q92670822A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy
Q41883466Angiogenic Factors and Cytokines in Diabetic Retinopathy
Q37304677Animal models of diabetic retinopathy: summary and comparison
Q35133785Antihypertensive effect of radix paeoniae alba in spontaneously hypertensive rats and excessive alcohol intake and high fat diet induced hypertensive rats
Q50962850Aqueous humor pentraxin-3 levels in patients with diabetes mellitus.
Q46443789Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy
Q24644700BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
Q64093346Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors
Q38143091Candidate genes for proliferative diabetic retinopathy
Q26744760Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Q36379507Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects
Q53612326Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.
Q35068037Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid
Q37084522Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy
Q33738829Current and future management of diabetic retinopathy: a personalized evidence-based approach
Q33791268Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.
Q81473347Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy
Q92130384Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network
Q58579972Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies
Q38542115Diabetic Retinopathy: Vascular and Inflammatory Disease.
Q35087841Diabetic complications and dysregulated innate immunity
Q41012046Diabetic retinopathy and inflammation: novel therapeutic targets.
Q35762905Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy
Q37362491Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.
Q34710173Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic rats
Q37501293Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation.
Q28199738Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus
Q92773331Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
Q35736321Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy.
Q39291225Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells.
Q33979446High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy
Q43143286High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.
Q36756478Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators
Q43137697IL-2 and IFN-gamma in the retina of diabetic rats.
Q36180464Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators
Q38167309Inflammation and pharmacological treatment in diabetic retinopathy
Q98288337Inflammatory and angiogenic biomarkers in diabetic retinopathy
Q37095335Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes
Q45001821Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes
Q33607728Interleukin-13 and age-related macular degeneration
Q51811242Intraocular Inflammation in Diabetic Populations.
Q94600699Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol
Q36082148Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications
Q37165322Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose
Q34273776Maternal immune system adaptation to pregnancy - a potential influence on the course of diabetic retinopathy
Q37734972Mesenchymal stem cells: new players in retinopathy therapy
Q54122676Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo.
Q26745555Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?
Q28078199Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Q34011852Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy
Q91643048Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy
Q92086083OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy
Q97550134Obesity-associated T-cell and macrophage activation improve partly after a lifestyle intervention
Q89659788Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile
Q26865897Pathophysiology of diabetic retinopathy
Q40072270Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in adult-onset familial Mediterranean fever.
Q36318318Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema
Q36294444Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus
Q37697860Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy
Q47361893Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.
Q38237215Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain
Q35220258Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease
Q42756101Proliferation and Migration of Peripheral Retinal Pigment Epithelial Cells Are Associated with the Upregulation of Wingless-Related Integration and Bone Morphogenetic Protein Signaling in Dark Agouti Rats
Q90311340Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy
Q79169175Relation between plasma nitric oxide levels and diabetic retinopathy
Q92594491Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography
Q52642996Role of Inflammation in Diabetic Retinopathy.
Q41012127Role of inflammation in the pathogenesis of diabetic retinopathy
Q94483947SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
Q42722361Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children
Q60947291Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
Q48277485Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography
Q47123777Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy
Q49551434TLR-induced secretion of novel cytokine IL-27 is defective in newly diagnosed type-2 diabetic subjects.
Q83396664The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus
Q50568033The Antioxidant and Antigenotoxic Effects of Pycnogenol® on Rats Treated With Cisplatin
Q48308877The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.
Q37647798The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions
Q42115589Thrombin-induced VEGF expression in human retinal pigment epithelial cells
Q35088004Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing
Q35609148Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
Q34426246Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy

Search more.